openPR Logo
Press release

Uveitis Treatment Market Expected to Reach $687 Million by 2026

11-23-2020 07:21 PM CET | Health & Medicine

Press release from: Allied Market Research

Uveitis Treatment Market

Uveitis Treatment Market

The growth of the uveitis market is attributed to rise in prevalence of uveitis disorders across the globe. Furthermore, growth in treatment awareness and rise in adoption of uveitis treatments contribute to the growth of the market.

Global uveitis treatment market size was valued at $478 million in 2018, and is projected to reach $687 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.

Downlode Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/6359

Uveitis is characterized by inflammation of the middle layer of the eye, which is called the uvea. It may occur from both infectious and non-infectious causes. Different types of medication such as cycloplegic agents, anti-inflammatory, and immunotherapy & targeted therapies, antimicrobial drugs, and others are used in the treatment of uveitis.

The uveitis treatment market is expected to experience significant growth during the forecast period, owing to rise in demand for uveitis treatment medication across geographies with increase in popularity advanced therapeutics. Furthermore, increase in prevalence of uveitis with early detection further boost the uveitis treatment market growth during the forecast period. However, lack of adverse effects associated with the use of drugs may hamper the market growth. Moreover, significant unmet need for uveitis treatment and innovative molecules in pipeline further create lucrative opportunities for uveitis treatment market.

Based on drug class, the uveitis market is categorized into anti-inflammatory, antimicrobial drugs, immunotherapy & targeted therapies, and others. Currently, anti-inflammatory is major revenue contributing segment and is estimated to witness significant market growth during the forecast period due to adoption of anti-inflammatory as first line treatment of uveitis. On the other hand, immunotherapy & targeted therapies segment is expected to witness fastest market growth due to rise in demand for ideal therapeutics for treatment of uveitis. Targeted therapies include biologic drugs that target certain parts of immune system to stop inflammation. Drugs such as abatacept, adalimumab, daclizumab, infliximab, rituximab, and others are used to treat severe uveitis.

According to distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The online providers segment is anticipated to depict significant growth during the forecast period due to rise in preference for online purchasing of drugs over the traditional methods, increase in awareness of online pharmacy, and rise in number of internet users.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/6359

Key Findings of the Study:

1. Based on drug class, the anti-inflammatory segment held approximately half of the share in the global market in 2018.
2. Based on distribution channel, the online pharmacies segment exhibits fastest growth and is expected to grow at a CAGR of 5.9% from 2019 to 2026.
3. Based on application, the anterior uveitis segment held largest market share in 2018 and is expected to remain dominant throughout the forecast period.
4. Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.0% during the forecast period.

North America accounted for approximately one-half of the global uveitis treatment market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of ideal uveitis treatment medication, higher number of R&D activities to develop ideal therapeutics, large number of target population with higher health awareness, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system. Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growth in prevalence of uveitis with increase in adoption of uveitis treatment medication.

Get detailed COVID-19 impact analysis on @ https://www.alliedmarketresearch.com/uveitis-treatment-market-A05994

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Treatment Market Expected to Reach $687 Million by 2026 here

News-ID: 2193779 • Views:

More Releases from Allied Market Research

Disposable Water Bottle Market to Reach $349.2 Million, Globally, by 2033 at 4.8% CAGR: Allied Market Research
Disposable Water Bottle Market to Reach $349.2 Million, Globally, by 2033 at 4.8 …
Allied Market Research published a report, titled, "Disposable Water Bottle Market by Type (Metal, Glass, Plastic and Paper), Application (Mineral Water Company, Drinks Company, Household Use and Others), Capacity (Small (15ml-100ml), Medium (100ml-500ml), Large (500ml-1000ml), and Others), and Distribution Channel (Online and Offline): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the global disposable water bottle market was valued at $220.0 million in 2023, and is projected
USD 6.3 Billion Smart Pillows Market Value Cross by 2033 | Top Players such as - Smart Sleep GmbH, Motion Pillow
USD 6.3 Billion Smart Pillows Market Value Cross by 2033 | Top Players such as - …
Smart pillows are gaining popularity in the expanding sleep technology market, combining comfort with advanced health monitoring capabilities with more people becoming aware of the importance of sleep for their health. Allied Market Research recently released a report on the global smart pillows market, highlighting key growth drivers, investment prospects, and challenges within the industry. Valued at $0.9 billion in 2023, the market is expected to grow to $6.3 billion
Interior Design Market to Surpass USD 216.1 Billion by 2034, Top Impacting Factors
Interior Design Market to Surpass USD 216.1 Billion by 2034, Top Impacting Facto …
Interior design is a multifaceted sector in which clients' criteria are used to finish or enhance an interior setting using inventive and technological design concepts. The interior design industry is made up of companies that specialize in the planning, designing, and administration of projects in a wide range of interior environments. For all projects, interior design firms and consultants must take into account the necessary building laws and health and
Carotenoids Market Worth Observing Growth Rate of 3.9% from 2022 to 2031 | BASF SE, FMC Corporation, Excelvite
Carotenoids Market Worth Observing Growth Rate of 3.9% from 2022 to 2031 | BASF …
Carotenoids market size was valued at $1.8 billion in 2021 and is estimated to reach $2.7 billion by 2031, growing at a CAGR of 3.9% from 2022 to 2031. The elder citizen constitutes a major percentage of the population in the developed regions and is the largest user of preventive and predictive medication such as carotenoids. Thus, the increase in demand for die tary supplements from the adult population is the

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &